Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety, Tolerability, and Efficacy of EA0010 in Patients With OTOF Mutations-Related Hearing Loss Who Have Received Cochlear Implantation

NCT07752888 is registered in ClinicalTrials.gov with Shanghai EmayGene Technology Co., Ltd as lead sponsor.

NCT NCT07752888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07752888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety, Tolerability, and Efficacy of EA0010 in Patients With OTOF Mutations-Related Hearing Loss Who Have Received Cochlear Implantation
Lead sponsor
Shanghai EmayGene Technology Co., Ltd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 23, 2026
Completion date
July 31, 2027
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cochlear implantation, dfnb9